| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | SELE HSPG2 CD248 LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 ARSA EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 MEX3B FBN3 NOTCH1 NOTCH3 PADI3 NOTCH4 CRB2 | 1.17e-10 | 749 | 154 | 26 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.05e-06 | 188 | 154 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | RAG1 MARCHF8 RNF213 MIB2 BIRC6 FBXL3 MEX3C PJA2 FBXO10 ZNRF3 RNF41 ARIH1 RNF39 LNX1 RFPL2 | 4.02e-06 | 473 | 154 | 15 | GO:0004842 |
| GeneOntologyMolecularFunction | integrin binding | 8.85e-06 | 175 | 154 | 9 | GO:0005178 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RAG1 MARCHF8 RNF213 MIB2 BIRC6 FBXL3 MEX3C PJA2 FBXO10 ZNRF3 RNF41 ARIH1 RNF39 LNX1 RFPL2 | 1.04e-05 | 512 | 154 | 15 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RAG1 MARCHF8 RNF213 MIB2 BIRC6 FBXL3 MEX3C PJA2 FBXO10 ZNRF3 RNF41 ARIH1 RNF39 LNX1 RFPL2 | 1.63e-05 | 532 | 154 | 15 | GO:0016755 |
| GeneOntologyMolecularFunction | inhibitory MHC class I receptor activity | 9.40e-05 | 12 | 154 | 3 | GO:0032396 | |
| GeneOntologyMolecularFunction | acyltransferase activity | RAG1 OGT MARCHF8 RNF213 CHAT MIB2 BIRC6 FBXL3 MEX3C PJA2 FBXO10 ZNRF3 RNF41 ARIH1 RNF39 LNX1 RFPL2 | 1.04e-04 | 775 | 154 | 17 | GO:0016746 |
| GeneOntologyMolecularFunction | ubiquitin protein ligase activity | RAG1 MARCHF8 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 RFPL2 | 1.51e-04 | 372 | 154 | 11 | GO:0061630 |
| GeneOntologyMolecularFunction | immunoglobulin binding | 1.65e-04 | 36 | 154 | 4 | GO:0019865 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | LILRA1 VWF ICAM2 ITGA8 LAMB1 CORO1B LILRB1 CCN6 CCN5 MFGE8 FBLN1 FBN1 TENM3 NOTCH3 | 2.29e-04 | 599 | 154 | 14 | GO:0050839 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.34e-04 | 16 | 154 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | RAG1 MARCHF8 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 RFPL2 | 2.71e-04 | 398 | 154 | 11 | GO:0061659 |
| GeneOntologyMolecularFunction | MHC class I receptor activity | 3.37e-04 | 18 | 154 | 3 | GO:0032393 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.40e-04 | 21 | 154 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | HLA-A specific inhibitory MHC class I receptor activity | 5.82e-04 | 5 | 154 | 2 | GO:0030107 | |
| GeneOntologyMolecularFunction | HLA-B specific inhibitory MHC class I receptor activity | 8.69e-04 | 6 | 154 | 2 | GO:0030109 | |
| GeneOntologyMolecularFunction | Notch binding | 1.15e-03 | 27 | 154 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | MHC class Ib protein complex binding | 1.21e-03 | 7 | 154 | 2 | GO:0023025 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | RAG1 OGT MARCHF8 RNF213 PTPN22 MIB2 BIRC6 FBXL3 AXIN1 PJA2 FBXO10 TULP4 ZNRF3 RNF41 ARIH1 RNF39 LNX1 RFPL2 VCPIP1 | 7.01e-06 | 811 | 150 | 19 | GO:0016567 |
| GeneOntologyBiologicalProcess | axon guidance | HSPG2 LAMB1 SEMA5A LAMC3 LHX3 SEMA5B SLIT3 LRP2 NOTCH1 NOTCH3 EPHA4 | 7.88e-06 | 285 | 150 | 11 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | HSPG2 LAMB1 SEMA5A LAMC3 LHX3 SEMA5B SLIT3 LRP2 NOTCH1 NOTCH3 EPHA4 | 8.14e-06 | 286 | 150 | 11 | GO:0097485 |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation | RAG1 OGT MARCHF8 RNF213 PTPN22 MIB2 BIRC6 FBXL3 AXIN1 PJA2 FBXO10 TULP4 ZNRF3 RNF41 ARIH1 RNF39 LNX1 RFPL2 VCPIP1 | 2.68e-05 | 893 | 150 | 19 | GO:0032446 |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 3.02e-05 | 25 | 150 | 4 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 3.02e-05 | 25 | 150 | 4 | GO:0050962 | |
| GeneOntologyBiologicalProcess | post-translational protein modification | RAG1 OGT MARCHF8 RNF213 PTPN22 MIB2 BIRC6 FBXL3 AXIN1 PJA2 FBXO10 TULP4 ZNRF3 PARP16 RNF41 ARIH1 RNF39 LNX1 USP48 RFPL2 VCPIP1 | 3.41e-05 | 1074 | 150 | 21 | GO:0043687 |
| GeneOntologyBiologicalProcess | distal tubule development | 4.36e-05 | 10 | 150 | 3 | GO:0072017 | |
| GeneOntologyBiologicalProcess | protein modification by small protein conjugation or removal | RAG1 OGT MARCHF8 RNF213 PTPN22 MIB2 BIRC6 FBXL3 AXIN1 PJA2 FBXO10 TULP4 ZNRF3 RNF41 ARIH1 RNF39 LNX1 USP48 RFPL2 VCPIP1 | 4.41e-05 | 1009 | 150 | 20 | GO:0070647 |
| GeneOntologyBiologicalProcess | interleukin-10-mediated signaling pathway | 5.96e-05 | 11 | 150 | 3 | GO:0140105 | |
| GeneOntologyBiologicalProcess | axonogenesis | HSPG2 MAP1A SZT2 LAMB1 SEMA5A ALS2 LAMC3 LHX3 SEMA5B SLIT3 LRP2 NOTCH1 NOTCH3 EPHA4 | 6.86e-05 | 566 | 150 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | HSPG2 MAP1A SZT2 LAMB1 PUM2 SEMA5A ALS2 LAMC3 LHX3 SEMA5B SLIT3 LRP2 NOTCH1 NOTCH3 EPHA4 | 7.11e-05 | 642 | 150 | 15 | GO:0061564 |
| GeneOntologyBiologicalProcess | kidney development | PCSK5 FRAS1 ITGA8 PGF FBN1 JAG1 LRP2 UMOD NOTCH1 NOTCH3 EPHA4 | 9.02e-05 | 372 | 150 | 11 | GO:0001822 |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 9.52e-05 | 63 | 150 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | HSPG2 LAMB1 SEMA5A PTPN22 LILRB1 FBLN1 ADAMDEC1 JAG1 NOTCH1 NOTCH4 EPHA4 | 9.68e-05 | 375 | 150 | 11 | GO:0007162 |
| GeneOntologyBiologicalProcess | renal system development | PCSK5 FRAS1 ITGA8 PGF FBN1 JAG1 LRP2 UMOD NOTCH1 NOTCH3 EPHA4 | 1.25e-04 | 386 | 150 | 11 | GO:0072001 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | SELE PCSK5 RAG1 HSPG2 LAMB1 SEMA5A PTPN22 LILRB1 FBLN1 TENM3 ADAMDEC1 JAG1 PEAK1 MEX3B PCK1 NOTCH1 NOTCH4 EPHA4 | 1.41e-04 | 927 | 150 | 18 | GO:0030155 |
| GeneOntologyBiologicalProcess | cell morphogenesis | HSPG2 MAP1A SZT2 ADAM7 LAMB1 SEMA5A ALS2 LAMC3 LHX3 CORO1B CRB1 FAT1 SEMA5B SLIT3 MKLN1 LRP2 NOTCH1 NOTCH3 NOTCH4 EPHA4 BRWD1 | 1.53e-04 | 1194 | 150 | 21 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 1.97e-04 | 16 | 150 | 3 | GO:0061101 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.59e-04 | 171 | 150 | 7 | GO:0048593 | |
| GeneOntologyBiologicalProcess | positive regulation of aorta morphogenesis | 3.12e-04 | 4 | 150 | 2 | GO:1903849 | |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 3.12e-04 | 4 | 150 | 2 | GO:0035583 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 FRAS1 VWF CD248 LAMB1 LAMC3 CCN6 CCN5 SSC5D MFGE8 FBLN1 EYS FBN1 FBN2 ADAMDEC1 HPX LTBP2 FBN3 | 2.48e-06 | 656 | 158 | 18 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 FRAS1 VWF CD248 LAMB1 LAMC3 CCN6 CCN5 SSC5D MFGE8 FBLN1 EYS FBN1 FBN2 ADAMDEC1 HPX LTBP2 FBN3 | 2.59e-06 | 658 | 158 | 18 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 FRAS1 VWF LAMB1 LAMC3 SSC5D MFGE8 FBLN1 EYS FBN1 FBN2 ADAMDEC1 HPX LTBP2 | 5.20e-05 | 530 | 158 | 14 | GO:0062023 |
| GeneOntologyCellularComponent | microfibril | 1.15e-04 | 13 | 158 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | basement membrane | 3.33e-04 | 122 | 158 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | subapical complex | 5.59e-04 | 5 | 158 | 2 | GO:0035003 | |
| GeneOntologyCellularComponent | cell surface | SELE LILRA1 VWF CD248 ITGA8 FAS LILRB1 MST1R CCN5 MFGE8 ARSA LYPLA1 SCUBE3 LRP2 UMOD NOTCH1 NOTCH3 NOTCH4 EPHA4 | 7.43e-04 | 1111 | 158 | 19 | GO:0009986 |
| Domain | EGF | SELE PCSK5 HSPG2 FRAS1 MUC3B CD248 LAMB1 LAMC3 LRP1B CRB1 MFGE8 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF TENM3 JAG1 SLIT3 SCUBE3 LRP2 UMOD ADAM33 LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 3.08e-28 | 235 | 158 | 31 | SM00181 |
| Domain | EGF-like_dom | SELE PCSK5 HSPG2 FRAS1 MUC3B CD248 LAMB1 LAMC3 LRP1B CRB1 MFGE8 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF TENM3 JAG1 SLIT3 SCUBE3 LRP2 UMOD ADAM33 LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 1.91e-27 | 249 | 158 | 31 | IPR000742 |
| Domain | Growth_fac_rcpt_ | PCSK5 HSPG2 FRAS1 CD248 LAMB1 LAMC3 LRP1B CRB1 CCN6 CCN5 FBLN1 EYS FAT1 FBN1 FBN2 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 | 1.75e-26 | 156 | 158 | 26 | IPR009030 |
| Domain | EGF_1 | SELE HSPG2 MUC3B CD248 LAMB1 LAMC3 LRP1B CRB1 MFGE8 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF TENM3 JAG1 SLIT3 SCUBE3 LRP2 UMOD ADAM33 LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 1.50e-24 | 255 | 158 | 29 | PS00022 |
| Domain | EGF_Ca-bd_CS | CD248 LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 4.39e-24 | 97 | 158 | 21 | IPR018097 |
| Domain | EGF_2 | SELE HSPG2 MUC3B CD248 LAMB1 LAMC3 LRP1B CRB1 MFGE8 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF TENM3 JAG1 SLIT3 SCUBE3 LRP2 UMOD ADAM33 LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 4.55e-24 | 265 | 158 | 29 | PS01186 |
| Domain | EGF_CA | CD248 LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 6.99e-24 | 99 | 158 | 21 | PS01187 |
| Domain | EGF_CA | HSPG2 CD248 LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 2.57e-23 | 122 | 158 | 22 | SM00179 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | CD248 LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 3.28e-23 | 106 | 158 | 21 | IPR000152 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 CD248 LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 3.76e-23 | 124 | 158 | 22 | IPR001881 |
| Domain | EGF-like_CS | SELE HSPG2 MUC3B CD248 LAMB1 LAMC3 LRP1B CRB1 MFGE8 FBLN1 EYS FAT1 FBN1 FBN2 EGF TENM3 JAG1 SLIT3 SCUBE3 LRP2 UMOD ADAM33 LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 5.15e-23 | 261 | 158 | 28 | IPR013032 |
| Domain | EGF_3 | SELE HSPG2 MUC3B CD248 LRP1B CRB1 MFGE8 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF TENM3 JAG1 SLIT3 SCUBE3 LRP2 UMOD ADAM33 LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 5.17e-23 | 235 | 158 | 27 | PS50026 |
| Domain | ASX_HYDROXYL | LRP1B CRB1 FBLN1 EYS FAT1 FBN1 FBN2 OIT3 EGF JAG1 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 1.01e-20 | 100 | 158 | 19 | PS00010 |
| Domain | EGF | SELE HSPG2 CD248 LRP1B CRB1 MFGE8 EYS FAT1 EGF JAG1 SLIT3 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 CRB2 | 4.07e-20 | 126 | 158 | 20 | PF00008 |
| Domain | EGF_CA | CD248 LRP1B FBLN1 FAT1 FBN1 FBN2 EGF JAG1 SCUBE3 LRP2 UMOD LTBP2 FBN3 NOTCH1 NOTCH3 NOTCH4 | 1.84e-17 | 86 | 158 | 16 | PF07645 |
| Domain | hEGF | 1.06e-12 | 28 | 158 | 9 | PF12661 | |
| Domain | cEGF | 1.56e-09 | 26 | 158 | 7 | PF12662 | |
| Domain | cEGF | 1.56e-09 | 26 | 158 | 7 | IPR026823 | |
| Domain | EGF_extracell | 3.87e-08 | 60 | 158 | 8 | IPR013111 | |
| Domain | EGF_2 | 3.87e-08 | 60 | 158 | 8 | PF07974 | |
| Domain | TB | 1.69e-07 | 7 | 158 | 4 | PF00683 | |
| Domain | Notch_dom | 1.69e-07 | 7 | 158 | 4 | IPR000800 | |
| Domain | Notch | 1.69e-07 | 7 | 158 | 4 | PF00066 | |
| Domain | NL | 1.69e-07 | 7 | 158 | 4 | SM00004 | |
| Domain | - | 3.36e-07 | 8 | 158 | 4 | 3.90.290.10 | |
| Domain | FBN | 5.94e-07 | 3 | 158 | 3 | IPR011398 | |
| Domain | TB_dom | 6.01e-07 | 9 | 158 | 4 | IPR017878 | |
| Domain | TB | 6.01e-07 | 9 | 158 | 4 | PS51364 | |
| Domain | LAM_G_DOMAIN | 7.36e-07 | 38 | 158 | 6 | PS50025 | |
| Domain | Laminin_G_2 | 1.01e-06 | 40 | 158 | 6 | PF02210 | |
| Domain | LamG | 1.80e-06 | 44 | 158 | 6 | SM00282 | |
| Domain | Notch | 2.36e-06 | 4 | 158 | 3 | IPR008297 | |
| Domain | NODP | 2.36e-06 | 4 | 158 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 2.36e-06 | 4 | 158 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 2.36e-06 | 4 | 158 | 3 | IPR010660 | |
| Domain | NOD | 2.36e-06 | 4 | 158 | 3 | PF06816 | |
| Domain | NOD | 2.36e-06 | 4 | 158 | 3 | SM01338 | |
| Domain | NODP | 2.36e-06 | 4 | 158 | 3 | SM01339 | |
| Domain | Znf_RING | RAG1 MARCHF8 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 LNX1 MEX3B RFPL2 | 4.21e-06 | 326 | 158 | 13 | IPR001841 |
| Domain | LNR | 5.87e-06 | 5 | 158 | 3 | PS50258 | |
| Domain | ZF_RING_2 | RAG1 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 LNX1 MEX3B RFPL2 | 9.04e-06 | 298 | 158 | 12 | PS50089 |
| Domain | Laminin_G | 9.38e-06 | 58 | 158 | 6 | IPR001791 | |
| Domain | RING | RAG1 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 LNX1 MEX3B RFPL2 | 1.14e-05 | 305 | 158 | 12 | SM00184 |
| Domain | Znf_C3HC4_RING-type | 1.60e-05 | 172 | 158 | 9 | IPR018957 | |
| Domain | - | 1.61e-05 | 95 | 158 | 7 | 2.60.120.200 | |
| Domain | ConA-like_dom | 1.77e-05 | 219 | 158 | 10 | IPR013320 | |
| Domain | zf-C3HC4 | 2.06e-05 | 223 | 158 | 10 | PF00097 | |
| Domain | LDLR_class-A_CS | 2.11e-05 | 40 | 158 | 5 | IPR023415 | |
| Domain | - | RAG1 MARCHF8 RSF1 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 LNX1 MEX3B RFPL2 | 2.89e-05 | 449 | 158 | 14 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | RAG1 MARCHF8 RSF1 RNF213 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 LNX1 MEX3B RFPL2 | 3.67e-05 | 459 | 158 | 14 | IPR013083 |
| Domain | Ldl_recept_a | 3.78e-05 | 45 | 158 | 5 | PF00057 | |
| Domain | ZF_RING_1 | RAG1 MIB2 MEX3C PJA2 ZNRF3 RNF41 ARIH1 RNF39 LNX1 MEX3B RFPL2 | 3.85e-05 | 291 | 158 | 11 | PS00518 |
| Domain | - | 4.21e-05 | 46 | 158 | 5 | 4.10.400.10 | |
| Domain | LDLRA_1 | 5.19e-05 | 48 | 158 | 5 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 5.74e-05 | 49 | 158 | 5 | IPR002172 | |
| Domain | LDLa | 5.74e-05 | 49 | 158 | 5 | SM00192 | |
| Domain | LDLRA_2 | 5.74e-05 | 49 | 158 | 5 | PS50068 | |
| Domain | Galactose-bd-like | 1.47e-04 | 94 | 158 | 6 | IPR008979 | |
| Domain | SEA | 2.02e-04 | 14 | 158 | 3 | SM00200 | |
| Domain | Ldl_recept_b | 2.02e-04 | 14 | 158 | 3 | PF00058 | |
| Domain | LDLRB | 2.02e-04 | 14 | 158 | 3 | PS51120 | |
| Domain | DUF3454 | 2.12e-04 | 3 | 158 | 2 | PF11936 | |
| Domain | DUF3454_notch | 2.12e-04 | 3 | 158 | 2 | IPR024600 | |
| Domain | DUF3454 | 2.12e-04 | 3 | 158 | 2 | SM01334 | |
| Domain | LY | 2.51e-04 | 15 | 158 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.51e-04 | 15 | 158 | 3 | IPR000033 | |
| Domain | VWC | 2.91e-04 | 38 | 158 | 4 | SM00214 | |
| Domain | - | 3.22e-04 | 39 | 158 | 4 | 2.120.10.30 | |
| Domain | - | 3.84e-04 | 73 | 158 | 5 | 2.60.120.260 | |
| Domain | PID_Shc-like | 4.22e-04 | 4 | 158 | 2 | IPR006019 | |
| Domain | VWF_dom | 4.30e-04 | 42 | 158 | 4 | IPR001007 | |
| Domain | CTCK_1 | 4.42e-04 | 18 | 158 | 3 | PS01185 | |
| Domain | VWC_out | 5.21e-04 | 19 | 158 | 3 | SM00215 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.10e-04 | 46 | 158 | 4 | IPR011042 | |
| Domain | Disintegrin | 7.06e-04 | 21 | 158 | 3 | PF00200 | |
| Domain | SRCR | 7.06e-04 | 21 | 158 | 3 | PF00530 | |
| Domain | DISIN | 7.06e-04 | 21 | 158 | 3 | SM00050 | |
| Domain | CUB | 7.77e-04 | 49 | 158 | 4 | PF00431 | |
| Domain | SEA | 8.13e-04 | 22 | 158 | 3 | PF01390 | |
| Domain | CT | 8.13e-04 | 22 | 158 | 3 | SM00041 | |
| Domain | CUB | 8.39e-04 | 50 | 158 | 4 | SM00042 | |
| Domain | NACHT | 9.29e-04 | 23 | 158 | 3 | PS50837 | |
| Domain | NACHT_NTPase | 9.29e-04 | 23 | 158 | 3 | IPR007111 | |
| Domain | SEA | 9.29e-04 | 23 | 158 | 3 | PS50024 | |
| Domain | SEA_dom | 9.29e-04 | 23 | 158 | 3 | IPR000082 | |
| Domain | - | 9.73e-04 | 52 | 158 | 4 | 2.60.120.290 | |
| Domain | A1B_glyco/leuk_Ig-like_rcpt | 1.04e-03 | 6 | 158 | 2 | IPR016332 | |
| Domain | CUB | 1.05e-03 | 53 | 158 | 4 | PS01180 | |
| Domain | Ephrin_rec_like | 1.19e-03 | 25 | 158 | 3 | SM01411 | |
| Domain | - | 1.19e-03 | 25 | 158 | 3 | 3.10.250.10 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.19e-03 | 25 | 158 | 3 | IPR011641 | |
| Domain | SR | 1.19e-03 | 25 | 158 | 3 | SM00202 | |
| Domain | Cys_knot_C | 1.19e-03 | 25 | 158 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.19e-03 | 25 | 158 | 3 | PS01225 | |
| Domain | - | 1.26e-03 | 248 | 158 | 8 | 1.25.40.20 | |
| Domain | SUSHI | 1.29e-03 | 56 | 158 | 4 | PS50923 | |
| Domain | SRCR-like_dom | 1.34e-03 | 26 | 158 | 3 | IPR017448 | |
| Domain | SRCR_1 | 1.34e-03 | 26 | 158 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.34e-03 | 26 | 158 | 3 | PS50287 | |
| Domain | Sushi_SCR_CCP_dom | 1.37e-03 | 57 | 158 | 4 | IPR000436 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 6.60e-07 | 37 | 121 | 6 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.91e-06 | 44 | 121 | 6 | M26969 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 1.99e-06 | 25 | 121 | 5 | M39713 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 2.42e-06 | 12 | 121 | 4 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 3.48e-06 | 13 | 121 | 4 | M47423 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 6.09e-06 | 5 | 121 | 3 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 6.09e-06 | 5 | 121 | 3 | MM14733 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | HSPG2 VWF ICAM2 ITGA8 LAMB1 LAMC3 FBLN1 FBN1 FBN2 SCUBE3 LTBP2 FBN3 | 1.02e-05 | 300 | 121 | 12 | M610 |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.21e-05 | 6 | 121 | 3 | M27068 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.95e-05 | 39 | 121 | 5 | MM14604 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.11e-05 | 7 | 121 | 3 | MM14734 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 4.44e-05 | 46 | 121 | 5 | M239 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 5.68e-05 | 25 | 121 | 4 | M27879 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 6.05e-05 | 49 | 121 | 5 | M618 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 7.78e-05 | 27 | 121 | 4 | M39545 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 9.68e-05 | 11 | 121 | 3 | M47865 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.28e-04 | 12 | 121 | 3 | M47533 | |
| Pathway | PID_NOTCH_PATHWAY | 1.48e-04 | 59 | 121 | 5 | M17 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 1.54e-04 | 32 | 121 | 4 | MM14854 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.66e-04 | 13 | 121 | 3 | M47534 | |
| Pathway | WP_FOCAL_ADHESION | 2.07e-04 | 187 | 121 | 8 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 2.60e-04 | 15 | 121 | 3 | M27202 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.74e-04 | 37 | 121 | 4 | M39506 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.90e-04 | 68 | 121 | 5 | M27303 | |
| Pathway | WP_FOCAL_ADHESION | 3.16e-04 | 199 | 121 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 3.16e-04 | 199 | 121 | 8 | M7253 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 3.18e-04 | 16 | 121 | 3 | M47424 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 3.37e-04 | 39 | 121 | 4 | MM14601 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 3.61e-04 | 154 | 121 | 7 | M39739 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 4.58e-04 | 18 | 121 | 3 | M614 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 5.41e-04 | 19 | 121 | 3 | MM15594 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 5.86e-04 | 45 | 121 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 6.38e-04 | 46 | 121 | 4 | MM15971 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 6.91e-04 | 82 | 121 | 5 | MM15922 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 6.93e-04 | 47 | 121 | 4 | M7946 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 7.71e-04 | 84 | 121 | 5 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.14e-04 | 85 | 121 | 5 | M16441 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 9.64e-04 | 23 | 121 | 3 | MM14954 | |
| Pathway | BIOCARTA_ERBB3_PATHWAY | 1.07e-03 | 6 | 121 | 2 | MM1543 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.09e-03 | 24 | 121 | 3 | M11190 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.30e-03 | 140 | 121 | 6 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.45e-03 | 143 | 121 | 6 | M27275 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 1.49e-03 | 7 | 121 | 2 | M27199 | |
| Pubmed | 2.25e-10 | 9 | 158 | 5 | 12122015 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCSK5 HSPG2 FRAS1 RIN3 SZT2 SHC1 LAMC3 MIB2 CORO1B STK11IP BIRC6 PLEKHM1 C2CD2L MST1R FAT1 TULP4 ZNRF3 NLRC5 AKAP13 DISP2 TOP3B NOTCH1 AGAP3 PPP1R16A | 2.28e-10 | 1105 | 158 | 24 | 35748872 |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 8.21e-10 | 11 | 158 | 5 | 9187150 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | PCSK5 HSPG2 VWF LAMB1 CCN5 SSC5D MFGE8 FBLN1 FBN1 ARSA SLIT3 LTBP2 | 1.74e-09 | 248 | 158 | 12 | 24006456 |
| Pubmed | 2.04e-09 | 5 | 158 | 4 | 20554499 | ||
| Pubmed | 2.04e-09 | 5 | 158 | 4 | 15882997 | ||
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 2.27e-09 | 13 | 158 | 5 | 20558824 | |
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 6.11e-09 | 6 | 158 | 4 | 12244553 | |
| Pubmed | 6.11e-09 | 6 | 158 | 4 | 17822320 | ||
| Pubmed | Notch controls the magnitude of T helper cell responses by promoting cellular longevity. | 6.11e-09 | 6 | 158 | 4 | 22615412 | |
| Pubmed | OGT MAP1A ACTR5 POLD1 BTBD18 RSF1 ANGEL1 LAMB1 RNF213 C2CD2L PJA2 FAT1 FBN2 ZNRF3 KMT5B INTS13 LRP2 ANKRD17 XYLB SEZ6L AGAP3 BRWD1 | 8.04e-09 | 1116 | 158 | 22 | 31753913 | |
| Pubmed | 1.42e-08 | 7 | 158 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.42e-08 | 7 | 158 | 4 | 12846471 | |
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 2.83e-08 | 8 | 158 | 4 | 12242716 | |
| Pubmed | 2.83e-08 | 8 | 158 | 4 | 9858718 | ||
| Pubmed | 2.83e-08 | 8 | 158 | 4 | 22156581 | ||
| Pubmed | 3.48e-08 | 21 | 158 | 5 | 28656980 | ||
| Pubmed | 5.08e-08 | 9 | 158 | 4 | 11118901 | ||
| Pubmed | 5.08e-08 | 9 | 158 | 4 | 16245338 | ||
| Pubmed | 5.72e-08 | 23 | 158 | 5 | 36239412 | ||
| Pubmed | 7.27e-08 | 118 | 158 | 8 | 21078624 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 8.43e-08 | 10 | 158 | 4 | 23665443 | |
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 9.20e-08 | 3 | 158 | 3 | 25846406 | |
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 14988227 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 15939383 | ||
| Pubmed | 9.20e-08 | 3 | 158 | 3 | 26341090 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.11e-07 | 26 | 158 | 5 | 34189436 | |
| Pubmed | 1.32e-07 | 11 | 158 | 4 | 10878608 | ||
| Pubmed | 1.32e-07 | 11 | 158 | 4 | 12866128 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.32e-07 | 11 | 158 | 4 | 15499562 | |
| Pubmed | 1.97e-07 | 12 | 158 | 4 | 15465494 | ||
| Pubmed | Functional analysis of secreted and transmembrane proteins critical to mouse development. | 2.80e-07 | 31 | 158 | 5 | 11431694 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.84e-07 | 13 | 158 | 4 | 11578869 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 28669409 | ||
| Pubmed | Heparin/heparan sulfate controls fibrillin-1, -2 and -3 self-interactions in microfibril assembly. | 3.67e-07 | 4 | 158 | 3 | 25034023 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 11401408 | ||
| Pubmed | Functional conservation of mouse Notch receptor family members. | 3.67e-07 | 4 | 158 | 3 | 8898100 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 36376768 | ||
| Pubmed | Deregulated expression of Notch receptors in human hepatocellular carcinoma. | 3.67e-07 | 4 | 158 | 3 | 17920003 | |
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 3.67e-07 | 4 | 158 | 3 | 28061457 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 11466531 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 24151014 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 21559424 | ||
| Pubmed | Mutational analysis of NOTCH1, 2, 3 and 4 genes in common solid cancers and acute leukemias. | 3.67e-07 | 4 | 158 | 3 | 18184405 | |
| Pubmed | Detection of Notch signaling molecules in cemento-ossifying fibroma of the jaws. | 3.67e-07 | 4 | 158 | 3 | 20040020 | |
| Pubmed | Notch signaling in the mammalian central nervous system: insights from mouse mutants. | 3.67e-07 | 4 | 158 | 3 | 15917835 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 24145721 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 3.67e-07 | 4 | 158 | 3 | 19404845 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 10551863 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 17984306 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 23444212 | ||
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 20819128 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 3.67e-07 | 4 | 158 | 3 | 10194420 | |
| Pubmed | 3.67e-07 | 4 | 158 | 3 | 11459941 | ||
| Pubmed | HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. | 3.67e-07 | 4 | 158 | 3 | 21270408 | |
| Pubmed | 3.96e-07 | 14 | 158 | 4 | 28192800 | ||
| Pubmed | 3.96e-07 | 14 | 158 | 4 | 14757642 | ||
| Pubmed | 5.38e-07 | 15 | 158 | 4 | 12971992 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 LRP12 FRAS1 LAMB1 RNF213 LAMC3 ERMP1 LRP1B MST1R FBLN1 FAT1 FBN1 FBN2 ARSA TENM3 SVIL LTBP2 USP48 NOTCH1 NOTCH3 | 5.98e-07 | 1201 | 158 | 20 | 35696571 |
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 17273555 | ||
| Pubmed | Notch signaling regulates remodeling and vessel diameter in the extraembryonic yolk sac. | 7.15e-07 | 16 | 158 | 4 | 21352545 | |
| Pubmed | 7.15e-07 | 16 | 158 | 4 | 10842072 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 7.15e-07 | 16 | 158 | 4 | 12617809 | |
| Pubmed | 8.97e-07 | 71 | 158 | 6 | 33541421 | ||
| Pubmed | Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. | 9.14e-07 | 5 | 158 | 3 | 11006133 | |
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 21124806 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 23675950 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 21602525 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 27118257 | ||
| Pubmed | 9.14e-07 | 5 | 158 | 3 | 11101851 | ||
| Pubmed | Development, composition, and structural arrangements of the ciliary zonule of the mouse. | 9.14e-07 | 5 | 158 | 3 | 23493297 | |
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 9.14e-07 | 5 | 158 | 3 | 15064243 | |
| Pubmed | 9.32e-07 | 17 | 158 | 4 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 9.32e-07 | 17 | 158 | 4 | 15821257 | |
| Pubmed | 1.04e-06 | 167 | 158 | 8 | 22159717 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 15689374 | ||
| Pubmed | 1.19e-06 | 18 | 158 | 4 | 18093989 | ||
| Pubmed | Generation of Distal Renal Segments Involves a Unique Population of Aqp2 + Progenitor Cells. | 1.51e-06 | 19 | 158 | 4 | 34667084 | |
| Pubmed | 1.51e-06 | 19 | 158 | 4 | 16518823 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 9111338 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 7835890 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 18299578 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 20870902 | ||
| Pubmed | Notch4 reveals a novel mechanism regulating Notch signal transduction. | 1.82e-06 | 6 | 158 | 3 | 24667410 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 9108364 | ||
| Pubmed | Notch lineages and activity in intestinal stem cells determined by a new set of knock-in mice. | 1.82e-06 | 6 | 158 | 3 | 21991352 | |
| Pubmed | Cloning and functional characterization of the murine mastermind-like 1 (Maml1) gene. | 1.82e-06 | 6 | 158 | 3 | 15019995 | |
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 22526456 | ||
| Pubmed | 1.82e-06 | 6 | 158 | 3 | 19503073 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 1.82e-06 | 6 | 158 | 3 | 19603167 | |
| Pubmed | Conversion of biliary system to pancreatic tissue in Hes1-deficient mice. | 2.31e-06 | 21 | 158 | 4 | 14702043 | |
| Pubmed | Uncontrolled angiogenic precursor expansion causes coronary artery anomalies in mice lacking Pofut1. | 2.66e-06 | 48 | 158 | 5 | 28924218 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 2.78e-06 | 86 | 158 | 6 | 28327460 | |
| Pubmed | FRAS1 PUM2 ALS2 NCDN C2CD2L PJA2 TENM3 DISP2 SEZ6L DOP1B VCPIP1 | 2.85e-06 | 407 | 158 | 11 | 12693553 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.97e-06 | 135 | 158 | 7 | 28675934 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 10383933 | ||
| Pubmed | Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. | 3.18e-06 | 7 | 158 | 3 | 11344305 | |
| Pubmed | 3.18e-06 | 7 | 158 | 3 | 19687229 | ||
| Pubmed | Impaired expression of Notch signaling genes in aged human skeletal muscle. | 3.18e-06 | 7 | 158 | 3 | 17301032 | |
| Interaction | IGFL3 interactions | 2.57e-10 | 75 | 153 | 10 | int:IGFL3 | |
| Interaction | NTN5 interactions | 3.93e-10 | 24 | 153 | 7 | int:NTN5 | |
| Interaction | ZFP41 interactions | 1.11e-08 | 57 | 153 | 8 | int:ZFP41 | |
| Interaction | FBXO2 interactions | PCSK5 HSPG2 FRAS1 ITGA8 LAMB1 LAMC3 LRP1B FBN1 FBN2 TENM3 JAG1 IQCB1 LRP2 ADAM33 NOTCH1 NOTCH3 | 1.00e-07 | 411 | 153 | 16 | int:FBXO2 |
| Interaction | ZNF408 interactions | 1.62e-07 | 145 | 153 | 10 | int:ZNF408 | |
| Interaction | PTPRK interactions | 1.03e-06 | 177 | 153 | 10 | int:PTPRK | |
| Interaction | MFAP5 interactions | 2.65e-06 | 52 | 153 | 6 | int:MFAP5 | |
| Interaction | DEFB125 interactions | 1.41e-05 | 20 | 153 | 4 | int:DEFB125 | |
| Interaction | ZNF224 interactions | 1.41e-05 | 20 | 153 | 4 | int:ZNF224 | |
| Interaction | TOP3B interactions | PCSK5 HSPG2 FRAS1 RIN3 SZT2 SHC1 LAMC3 MIB2 CORO1B STK11IP BIRC6 PLEKHM1 C2CD2L MST1R FAT1 TULP4 ZNRF3 SVIL NLRC5 ANKRD17 AKAP13 DISP2 TOP3B MEX3B NOTCH1 AGAP3 PPP1R16A | 1.55e-05 | 1470 | 153 | 27 | int:TOP3B |
| Interaction | HOXA1 interactions | PCSK5 VWF CCN5 FBLN1 SSC4D FBN1 OIT3 ZNRF3 LNX1 NOTCH1 NOTCH3 AGAP3 | 1.82e-05 | 356 | 153 | 12 | int:HOXA1 |
| Interaction | C2CD4B interactions | 2.02e-05 | 44 | 153 | 5 | int:C2CD4B | |
| Interaction | GPHA2 interactions | 3.57e-05 | 25 | 153 | 4 | int:GPHA2 | |
| Interaction | SUSD4 interactions | 3.80e-05 | 50 | 153 | 5 | int:SUSD4 | |
| Interaction | LGALS1 interactions | FRAS1 RIN3 ICAM2 ITGA8 LAMB1 TENM3 JAG1 LRP2 UQCRFS1 NOTCH1 NOTCH3 | 4.79e-05 | 332 | 153 | 11 | int:LGALS1 |
| Interaction | LILRA1 interactions | 5.73e-05 | 2 | 153 | 2 | int:LILRA1 | |
| Interaction | ELN interactions | 6.54e-05 | 29 | 153 | 4 | int:ELN | |
| Interaction | ZNF517 interactions | 6.54e-05 | 29 | 153 | 4 | int:ZNF517 | |
| Interaction | PRG2 interactions | PCSK5 HSPG2 FRAS1 LAMC3 MST1R FBN2 MKLN1 USP48 NOTCH1 NOTCH3 | 6.63e-05 | 285 | 153 | 10 | int:PRG2 |
| Interaction | LILRA3 interactions | 6.77e-05 | 11 | 153 | 3 | int:LILRA3 | |
| Interaction | MFAP2 interactions | 8.98e-05 | 12 | 153 | 3 | int:MFAP2 | |
| Interaction | TRIP6 interactions | RIN3 TNIP2 RNF213 MIB2 FAS AXIN1 FBXO10 SVIL LNX1 MEX3B PPP1R16A | 9.40e-05 | 358 | 153 | 11 | int:TRIP6 |
| Interaction | CA1 interactions | 1.16e-04 | 13 | 153 | 3 | int:CA1 | |
| Interaction | SLURP1 interactions | 1.17e-04 | 144 | 153 | 7 | int:SLURP1 | |
| Interaction | IGSF5 interactions | 1.47e-04 | 14 | 153 | 3 | int:IGSF5 | |
| Interaction | DLK2 interactions | 1.56e-04 | 36 | 153 | 4 | int:DLK2 | |
| Interaction | LTBP4 interactions | 1.56e-04 | 67 | 153 | 5 | int:LTBP4 | |
| Interaction | GLUD1 interactions | 1.61e-04 | 258 | 153 | 9 | int:GLUD1 | |
| Interaction | ST14 interactions | 1.88e-04 | 207 | 153 | 8 | int:ST14 | |
| Interaction | VEGFD interactions | 1.93e-04 | 38 | 153 | 4 | int:VEGFD | |
| Interaction | DLL1 interactions | 1.93e-04 | 38 | 153 | 4 | int:DLL1 | |
| Interaction | JAG2 interactions | 1.94e-04 | 110 | 153 | 6 | int:JAG2 | |
| GeneFamily | Ring finger proteins | RAG1 MARCHF8 RNF213 MEX3C PJA2 ZNRF3 RNF41 RNF39 LNX1 MEX3B RFPL2 | 1.33e-06 | 275 | 114 | 11 | 58 |
| GeneFamily | Low density lipoprotein receptors | 6.67e-05 | 13 | 114 | 3 | 634 | |
| GeneFamily | NLR family | 5.07e-04 | 25 | 114 | 3 | 666 | |
| GeneFamily | CYR61/CTGF/NOV matricellular proteins | 5.81e-04 | 6 | 114 | 2 | 1046 | |
| GeneFamily | CD molecules|Activating leukocyte immunoglobulin like receptors | 5.81e-04 | 6 | 114 | 2 | 1181 | |
| GeneFamily | Ankyrin repeat domain containing | 8.62e-04 | 242 | 114 | 7 | 403 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.76e-04 | 394 | 114 | 9 | 471 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.38e-03 | 9 | 114 | 2 | 1223 | |
| GeneFamily | VPS9 domain containing | 1.72e-03 | 10 | 114 | 2 | 928 | |
| GeneFamily | Laminin subunits | 2.50e-03 | 12 | 114 | 2 | 626 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.58e-03 | 57 | 114 | 3 | 1179 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 VWF LAMB1 LAMC3 CCN6 CCN5 MFGE8 FBLN1 EYS FBN1 FBN2 OIT3 SLIT3 LTBP2 FBN3 | 7.37e-13 | 196 | 154 | 15 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FRAS1 VWF LAMB1 LAMC3 CCN6 CCN5 MFGE8 FBLN1 EYS FBN1 FBN2 OIT3 SLIT3 LTBP2 FBN3 | 8.15e-12 | 275 | 154 | 16 | M5884 |
| Coexpression | NABA_MATRISOME | PAPPA2 PCSK5 HSPG2 FRAS1 TMPRSS15 VWF ADAM7 LAMB1 SEMA5A LAMC3 PGF CCN6 CCN5 MFGE8 FBLN1 EYS FBN1 FBN2 OIT3 EGF ADAMDEC1 SEMA5B SLIT3 HPX SCUBE3 ADAM33 LTBP2 FBN3 | 1.05e-11 | 1026 | 154 | 28 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | FRAS1 VWF LAMB1 LAMC3 CCN6 CCN5 MFGE8 FBLN1 FBN1 FBN2 OIT3 SLIT3 LTBP2 | 1.16e-10 | 191 | 154 | 13 | MM17059 |
| Coexpression | NABA_MATRISOME | PAPPA2 PCSK5 HSPG2 FRAS1 TMPRSS15 VWF ADAM7 LAMB1 SEMA5A LAMC3 PGF CCN6 CCN5 MFGE8 FBLN1 FBN1 FBN2 OIT3 EGF ADAMDEC1 SEMA5B SLIT3 HPX SCUBE3 ADAM33 LTBP2 | 2.14e-10 | 1008 | 154 | 26 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 FRAS1 VWF LAMB1 LAMC3 CCN6 CCN5 MFGE8 FBLN1 FBN1 FBN2 OIT3 SLIT3 LTBP2 | 7.88e-10 | 270 | 154 | 14 | MM17057 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 5.19e-07 | 162 | 154 | 9 | M45037 | |
| Coexpression | JONES_OVARY_NK_CELL | 9.70e-07 | 89 | 154 | 7 | M48353 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.97e-06 | 16 | 154 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.97e-06 | 16 | 154 | 4 | M2207 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | MAP1A CD248 SHC1 LAMB1 LAMC3 SSC5D MFGE8 FAT1 FBN1 JAG1 SVIL AKAP13 LTBP2 PEAK1 NOTCH1 NOTCH3 | 2.79e-06 | 681 | 154 | 16 | M39175 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | CD248 SHC1 ITGA8 LAMB1 RNF213 SEMA5A LAMC3 CPED1 PGF C2CD2L MFGE8 FBN1 JAG1 SVIL PLCL1 PEAK1 NOTCH3 | 4.71e-06 | 795 | 154 | 17 | M39050 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.71e-05 | 137 | 154 | 7 | M40313 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | CD248 LAMB1 LAMC3 CPED1 PGF FBLN1 FBN1 FBN2 JAG1 SVIL NOTCH3 | 1.84e-05 | 385 | 154 | 11 | M39264 |
| Coexpression | GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP | 1.88e-05 | 139 | 154 | 7 | M433 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.53e-05 | 261 | 154 | 9 | M1834 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | VWF LAMC3 CPED1 PGF MFGE8 FBLN1 FBN1 ADAMDEC1 ADAM33 LTBP2 NOTCH3 NOTCH4 | 4.64e-05 | 505 | 154 | 12 | M39167 |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 6.31e-05 | 365 | 154 | 10 | M39018 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SURVIVAL_UP | 7.14e-05 | 73 | 154 | 5 | M6939 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL | 7.88e-05 | 174 | 154 | 7 | M45676 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 8.02e-05 | 303 | 154 | 9 | M39040 | |
| Coexpression | JONES_OVARY_MACROPHAGE | 9.92e-05 | 243 | 154 | 8 | M48355 | |
| Coexpression | HALLMARK_WNT_BETA_CATENIN_SIGNALING | 1.08e-04 | 42 | 154 | 4 | M5895 | |
| Coexpression | GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP | 1.70e-04 | 197 | 154 | 7 | M4434 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN | 1.81e-04 | 199 | 154 | 7 | M9323 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 1.81e-04 | 199 | 154 | 7 | M3417 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 1.87e-04 | 200 | 154 | 7 | M3575 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | HSPG2 LAMB1 SEMA5A CPED1 PGF MFGE8 FBLN1 FAT1 FBN1 TENM3 JAG1 SLIT3 LTBP2 NOTCH3 | 4.45e-06 | 455 | 150 | 14 | GSM777055_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | PAPPA2 TMPRSS15 MAP1A CD248 ITGA8 SEMA5A CHAT CPED1 LRP1B CRB1 SSC5D MOXD1 FBN1 FBN2 SLIT3 HPX SCUBE3 LRP2 ADAM33 LTBP2 SEZ6L CRB2 | 9.00e-06 | 1094 | 150 | 22 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.69e-05 | 207 | 150 | 9 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | SELE HSPG2 ITGA8 LAMB1 SEMA5A CPED1 MFGE8 FBLN1 FAT1 FBN1 TENM3 JAG1 SLIT3 | 1.72e-05 | 445 | 150 | 13 | GSM777043_500 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.72e-05 | 261 | 150 | 10 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 2.32e-05 | 165 | 150 | 8 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | PAPPA2 MAP1A CD248 ITGA8 CPED1 MFGE8 FBLN1 FBN1 FBN2 TENM3 MEX3B | 2.86e-05 | 337 | 150 | 11 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 PCSK5 CD248 ITGA8 LAMB1 RNF213 SEMA5A CPED1 MFGE8 FBLN1 FAT1 FBN1 FBN2 TENM3 JAG1 SVIL VCPIP1 | 3.14e-05 | 768 | 150 | 17 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | PCSK5 FRAS1 MAP1A CD248 ITGA8 LAMB1 RNF213 CPED1 PGF FBLN1 FBN1 FBN2 TENM3 JAG1 SVIL PEAK1 MEX3B | 3.63e-05 | 777 | 150 | 17 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.35e-05 | 310 | 150 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 7.70e-05 | 62 | 150 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.73e-05 | 199 | 150 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_1000 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 9.66e-05 | 65 | 150 | 5 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | PAPPA2 CD248 ITGA8 LAMB1 RNF213 SEMA5A CPED1 PGF FBLN1 FAT1 FBN1 FBN2 TENM3 JAG1 SVIL PEAK1 | 1.19e-04 | 773 | 150 | 16 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | HSPG2 MARCHF8 LAMB1 SEMA5A PGF MFGE8 FBLN1 FAT1 FBN1 TENM3 SLIT3 NOTCH3 | 1.21e-04 | 466 | 150 | 12 | GSM777050_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | PAPPA2 FRAS1 LAMB1 SEMA5A ERMP1 FBN2 JAG1 SCUBE3 LRP2 NOTCH1 EPHA4 | 1.27e-04 | 398 | 150 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_500 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | PAPPA2 FRAS1 LAMB1 SEMA5A ERMP1 FBLN1 MOXD1 FBN1 FBN2 TENM3 ZNRF3 JAG1 SCUBE3 LRP2 NOTCH1 EPHA4 | 1.38e-04 | 783 | 150 | 16 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | BM Top 100 - kidney medulla | 1.79e-04 | 74 | 150 | 5 | BM Top 100 - kidney medulla | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.81e-04 | 166 | 150 | 7 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.89e-04 | 348 | 150 | 10 | gudmap_kidney_adult_Mesangium_Meis_k2_1000 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_2500_k-means-cluster#5 | PAPPA2 CD248 ITGA8 SEMA5A FAS CPED1 SSC5D FBLN1 MOXD1 FAT1 FBN1 SLIT3 SCUBE3 ADAM33 RNF41 PEAK1 | 2.14e-04 | 814 | 150 | 16 | JC_fibro_2500_K5 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 2.32e-04 | 122 | 150 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | ITGA8 LAMB1 SEMA5A CPED1 FBN2 TENM3 JAG1 SCUBE3 NOTCH1 EPHA4 | 3.09e-04 | 370 | 150 | 10 | gudmap_kidney_P3_CapMes_Crym_500 |
| CoexpressionAtlas | thyroid gland | 3.14e-04 | 240 | 150 | 8 | thyroid gland | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | HSPG2 ITGA8 LAMB1 SEMA5A CPED1 MFGE8 FAT1 FBN1 JAG1 SLIT3 NOTCH3 | 3.85e-04 | 453 | 150 | 11 | GSM777067_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | PAPPA2 CD248 ITGA8 SEMA5A MFGE8 FBN1 JAG1 SLIT3 LRP2 UMOD NOTCH3 | 4.07e-04 | 456 | 150 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | PAPPA2 CD248 ITGA8 SEMA5A CHAT CRB1 SSC5D MOXD1 FBN1 SLIT3 HPX SCUBE3 LRP2 LTBP2 FBN3 SEZ6L CRB2 | 4.08e-04 | 951 | 150 | 17 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | WSCD1 SZT2 ITGA8 CPED1 PGF RBM20 MOXD1 FBN2 KMT5B INTS13 MKLN1 SCUBE3 UMOD AKAP13 IFT122 | 4.21e-04 | 779 | 150 | 15 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | PAPPA2 WSCD1 OGT ITGA8 LAMB1 SEMA5A BIRC6 JAG1 MKLN1 SCUBE3 LRP2 UMOD AKAP13 EPHA4 BRWD1 | 5.20e-04 | 795 | 150 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.36e-04 | 397 | 150 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 6.05e-04 | 146 | 150 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 6.29e-04 | 97 | 150 | 5 | GSM777043_100 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 6.50e-04 | 148 | 150 | 6 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.58e-04 | 336 | 150 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | PAPPA2 ITGA8 CHAT CPED1 LRP1B CRB1 MOXD1 SEMA5B TMEM132D SLIT3 HPX SCUBE3 LRP2 PLCL1 FBN3 SEZ6L CRB2 | 6.71e-04 | 994 | 150 | 17 | PCBC_EB_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | PAPPA2 CD248 ITGA8 SEMA5A PGF PJA2 MFGE8 FBN1 JAG1 SLIT3 SCUBE3 LRP2 UMOD PLCL1 PEAK1 NOTCH3 | 6.83e-04 | 905 | 150 | 16 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | PCSK5 FRAS1 ITGA8 LAMB1 LAMC3 CCN5 SSC5D FBLN1 MOXD1 FBN1 SLIT3 LTBP2 | 3.99e-12 | 191 | 156 | 12 | e30ae7a12439f8a79820b13f03e822c1223fd0cb |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | PCSK5 FRAS1 ITGA8 LAMB1 LAMC3 CCN5 SSC5D FBLN1 MOXD1 FBN1 SLIT3 LTBP2 | 3.99e-12 | 191 | 156 | 12 | 1726add3f392a061536b7aff72ba84303f4a0b1f |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | ITGA8 LAMB1 LAMC3 PGF CCN5 FBLN1 MOXD1 FBN1 TENM3 SLIT3 LTBP2 NOTCH3 | 5.09e-12 | 195 | 156 | 12 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | ITGA8 LAMB1 LAMC3 PGF CCN5 FBLN1 MOXD1 FBN1 TENM3 SLIT3 LTBP2 NOTCH3 | 5.09e-12 | 195 | 156 | 12 | c269c0d894a0f55da6495b59d4b9abb9f68df684 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CD248 ITGA8 LAMB1 LAMC3 CCN5 MFGE8 FBLN1 MOXD1 FBN1 SLIT3 ADAM33 LTBP2 | 6.10e-12 | 198 | 156 | 12 | aae663c6da70b6e716edeed50cc7d3962d78e697 |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CD248 ITGA8 LAMB1 LAMC3 CCN5 MFGE8 FBLN1 MOXD1 FBN1 SLIT3 LTBP2 NOTCH3 | 6.86e-12 | 200 | 156 | 12 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CD248 ITGA8 LAMB1 LAMC3 CCN5 MFGE8 FBLN1 MOXD1 FBN1 SLIT3 LTBP2 NOTCH3 | 6.86e-12 | 200 | 156 | 12 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | Biopsy_IPF-Mesenchymal|Biopsy_IPF / Sample group, Lineage and Cell type | CD248 ITGA8 LAMB1 CCN5 SSC5D MFGE8 FBLN1 MOXD1 FBN1 SLIT3 ADAM33 LTBP2 | 6.86e-12 | 200 | 156 | 12 | bb605b373caf3f873dc1b87d712704568e0d6040 |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | CD248 ITGA8 LAMB1 CCN5 SSC5D MFGE8 FBLN1 MOXD1 FBN1 SLIT3 LTBP2 NOTCH3 | 6.86e-12 | 200 | 156 | 12 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CD248 PGF CCN5 SSC5D MFGE8 FBLN1 MOXD1 FBN1 SLIT3 ADAM33 LTBP2 | 7.35e-11 | 189 | 156 | 11 | d531399749409d614adca13d181830c6e3287508 |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | PAPPA2 CD248 ITGA8 PGF CCN5 SSC5D FBN1 SCUBE3 ADAM33 LTBP2 NOTCH3 | 1.21e-10 | 198 | 156 | 11 | b258f672529fb2c03e62e2696d335043c4963280 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CD248 ITGA8 LAMB1 CCN5 MFGE8 FBLN1 MOXD1 FBN1 SLIT3 ADAM33 LTBP2 | 1.28e-10 | 199 | 156 | 11 | 0019cfaa586a450c2e4952d1184a540561c8d0ba |
| ToppCell | distal-mesenchymal|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CD248 ITGA8 LAMB1 LAMC3 CCN5 MFGE8 FBLN1 MOXD1 SLIT3 LTBP2 NOTCH3 | 1.35e-10 | 200 | 156 | 11 | b54137a4545690f51e154bb05964eaa650c3ca8e |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | CD248 ITGA8 LAMB1 CCN5 SSC5D FBLN1 MOXD1 FBN1 SLIT3 ADAM33 LTBP2 | 1.35e-10 | 200 | 156 | 11 | 6e3d1ae0ef84d3075afa40129a41169996462672 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | SEMA5A CPED1 RBM20 MFGE8 FAT1 SEMA5B JAG1 SLIT3 PLCL1 NOTCH3 | 1.19e-09 | 186 | 156 | 10 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | MAP1A ITGA8 SEMA5A PGF CCN5 SEMA5B SLIT3 SCUBE3 ADAM33 NOTCH3 | 1.32e-09 | 188 | 156 | 10 | 6ec22b79b19d57ea187f312907819dc2d01f3efe |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | SEMA5A PGF CCN5 SEMA5B SLIT3 SCUBE3 ADAM33 LTBP2 NOTCH3 PADI3 | 1.39e-09 | 189 | 156 | 10 | b5439ef221106f6d54434f268485e9bb17b39102 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | SEMA5A CPED1 RBM20 MFGE8 FAT1 SEMA5B JAG1 SLIT3 ADAM33 NOTCH3 | 1.46e-09 | 190 | 156 | 10 | d6b3a92119b210974a32af3fe9875d60eb02761e |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | SEMA5A CPED1 RBM20 MFGE8 FAT1 SEMA5B JAG1 SLIT3 ADAM33 NOTCH3 | 1.54e-09 | 191 | 156 | 10 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-09 | 192 | 156 | 10 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-09 | 192 | 156 | 10 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.70e-09 | 193 | 156 | 10 | b05361ffe111a38cfa26eb86e4ae62c15ac99b7b | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-09 | 193 | 156 | 10 | 469a7f1c2ff7137cc5a064464456911f67f92e70 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | ITGA8 CCN5 MFGE8 FBN1 SEMA5B SLIT3 SCUBE3 ADAM33 LTBP2 NOTCH3 | 1.70e-09 | 193 | 156 | 10 | 800b0f5705fefcd3608e37801afae8a94474723e |
| ToppCell | metastatic_Brain-Fibroblasts-Pericytes|metastatic_Brain / Location, Cell class and cell subclass | 1.79e-09 | 194 | 156 | 10 | d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.79e-09 | 194 | 156 | 10 | 02b8102be9414d6964cd71019613edff6d88b893 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | HSPG2 MAP1A ITGA8 CPED1 CCN5 MFGE8 SCUBE3 ADAM33 LTBP2 NOTCH3 | 1.79e-09 | 194 | 156 | 10 | aaecde88bd54134a938e76cdf059c1c2653e4e77 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-09 | 195 | 156 | 10 | edd4cd8402af81737b2074f9dce71cc6ab09be7e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-09 | 195 | 156 | 10 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-09 | 196 | 156 | 10 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.97e-09 | 196 | 156 | 10 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-09 | 196 | 156 | 10 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.97e-09 | 196 | 156 | 10 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.97e-09 | 196 | 156 | 10 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | HSPG2 MAP1A ITGA8 CPED1 CCN5 MFGE8 SCUBE3 ADAM33 LTBP2 NOTCH3 | 1.97e-09 | 196 | 156 | 10 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.18e-09 | 198 | 156 | 10 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-09 | 199 | 156 | 10 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-09 | 199 | 156 | 10 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.29e-09 | 199 | 156 | 10 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.29e-09 | 199 | 156 | 10 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-09 | 199 | 156 | 10 | 4e128c705ad36fd840582848f278770f356fcc8b | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.29e-09 | 199 | 156 | 10 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.29e-09 | 199 | 156 | 10 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.40e-09 | 200 | 156 | 10 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-09 | 200 | 156 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.40e-09 | 200 | 156 | 10 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-09 | 200 | 156 | 10 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.40e-09 | 200 | 156 | 10 | ba5ed66b05caa1be0bbf8d54c4e72a782b8d9833 | |
| ToppCell | distal-2-mesenchymal|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | CD248 LAMB1 SEMA5A LAMC3 CCN5 MFGE8 FBLN1 SLIT3 LTBP2 NOTCH3 | 2.40e-09 | 200 | 156 | 10 | 65a50f03b0027ccefb51b8f77afa283d4a3b3567 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-09 | 200 | 156 | 10 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.40e-09 | 200 | 156 | 10 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.15e-08 | 174 | 156 | 9 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | COVID-19-kidney-REN+Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.47e-08 | 179 | 156 | 9 | 342c1cc4444f51b8dcb30d3adc98285a25669c6e | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-08 | 183 | 156 | 9 | 4060d979948e1dd7507977629a7fbdfa4ca65bb6 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.78e-08 | 183 | 156 | 9 | 0d44a978221cf3f733704bf11863502805fba733 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-08 | 186 | 156 | 9 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.15e-08 | 187 | 156 | 9 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.15e-08 | 187 | 156 | 9 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-08 | 188 | 156 | 9 | 2ee64bc73a2251fd9f374be759b442cf4ed0d19e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-08 | 188 | 156 | 9 | e18065bbc26d6f3774fd1f478fb41d8fb555fa26 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-08 | 190 | 156 | 9 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-08 | 190 | 156 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-08 | 190 | 156 | 9 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-08 | 190 | 156 | 9 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-08 | 191 | 156 | 9 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.58e-08 | 191 | 156 | 9 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-08 | 191 | 156 | 9 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.58e-08 | 191 | 156 | 9 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-08 | 191 | 156 | 9 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-08 | 191 | 156 | 9 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-08 | 191 | 156 | 9 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-08 | 192 | 156 | 9 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-08 | 192 | 156 | 9 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-08 | 192 | 156 | 9 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.70e-08 | 192 | 156 | 9 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.70e-08 | 192 | 156 | 9 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-08 | 192 | 156 | 9 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.70e-08 | 192 | 156 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-08 | 192 | 156 | 9 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.70e-08 | 192 | 156 | 9 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-08 | 192 | 156 | 9 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-08 | 192 | 156 | 9 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-08 | 193 | 156 | 9 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-08 | 193 | 156 | 9 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.83e-08 | 193 | 156 | 9 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.83e-08 | 193 | 156 | 9 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-08 | 193 | 156 | 9 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.83e-08 | 193 | 156 | 9 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.83e-08 | 193 | 156 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.83e-08 | 193 | 156 | 9 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.83e-08 | 193 | 156 | 9 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-08 | 194 | 156 | 9 | 29f83cdd63314fff41258937d70b881a5503bfcc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.95e-08 | 194 | 156 | 9 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-08 | 194 | 156 | 9 | d3db241ea316bbcde6d16618193b474591ad5ce4 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.95e-08 | 194 | 156 | 9 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-08 | 195 | 156 | 9 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-08 | 195 | 156 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-08 | 195 | 156 | 9 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.09e-08 | 195 | 156 | 9 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.09e-08 | 195 | 156 | 9 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| Computational | Metal / Ca ion binding. | 3.18e-05 | 133 | 100 | 8 | MODULE_324 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.58e-05 | 50 | 100 | 5 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.34e-07 | 3 | 152 | 3 | DOID:65 (implicated_via_orthology) | |
| Disease | alkaline phosphatase measurement | SELE HSPG2 RIN3 MAP1A PTPN22 ERMP1 PGF PLEKHM1 AXIN1 MFGE8 ZNRF3 IQCB1 SCUBE3 AKAP13 LTBP2 PLCL1 USP48 PCK1 NOTCH1 | 1.28e-06 | 1015 | 152 | 19 | EFO_0004533 |
| Disease | Carcinoma, Pancreatic Ductal | 6.64e-06 | 24 | 152 | 4 | C0887833 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 7.36e-06 | 8 | 152 | 3 | DOID:4783 (biomarker_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 1.72e-05 | 156 | 152 | 7 | C0235480 | |
| Disease | familial atrial fibrillation | 1.72e-05 | 156 | 152 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 1.72e-05 | 156 | 152 | 7 | C2585653 | |
| Disease | Atrial Fibrillation | 2.02e-05 | 160 | 152 | 7 | C0004238 | |
| Disease | Glioblastoma | 5.63e-05 | 79 | 152 | 5 | C0017636 | |
| Disease | vital capacity | PAPPA2 PCSK5 HSPG2 RIN3 HKDC1 LHX3 RBM20 PLEKHM1 TULP4 LRP2 DISP2 LTBP2 PLCL1 XYLB LNX1 NLRP4 FBN3 AGAP3 | 7.10e-05 | 1236 | 152 | 18 | EFO_0004312 |
| Disease | Giant Cell Glioblastoma | 7.55e-05 | 84 | 152 | 5 | C0334588 | |
| Disease | Weill-Marchesani syndrome | 7.88e-05 | 3 | 152 | 2 | C0265313 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 7.88e-05 | 3 | 152 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 7.88e-05 | 3 | 152 | 2 | C1869114 | |
| Disease | descending aortic diameter | 9.43e-05 | 88 | 152 | 5 | EFO_0021788 | |
| Disease | Kidney Diseases | 9.43e-05 | 88 | 152 | 5 | C0022658 | |
| Disease | Carcinoma of bladder | 1.03e-04 | 18 | 152 | 3 | C0699885 | |
| Disease | carotid artery disease (is_marker_for) | 1.22e-04 | 19 | 152 | 3 | DOID:3407 (is_marker_for) | |
| Disease | body surface area | PAPPA2 PCSK5 MCPH1 LHX3 CPED1 AXIN1 FBN1 FBN2 SLIT3 AKAP13 LTBP2 EPHA4 | 1.32e-04 | 643 | 152 | 12 | EFO_0022196 |
| Disease | scoliosis (is_implicated_in) | 1.57e-04 | 4 | 152 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Uveomeningoencephalitic Syndrome | 1.57e-04 | 4 | 152 | 2 | C0042170 | |
| Disease | Weill-Marchesani syndrome | 1.57e-04 | 4 | 152 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 1.57e-04 | 4 | 152 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.63e-04 | 53 | 152 | 4 | C4707243 | |
| Disease | systemic scleroderma (is_implicated_in) | 2.51e-04 | 24 | 152 | 3 | DOID:418 (is_implicated_in) | |
| Disease | COVID-19, mortality | 2.59e-04 | 170 | 152 | 6 | EFO_0004352, MONDO_0100096 | |
| Disease | adult T-cell leukemia/lymphoma (is_implicated_in) | 2.61e-04 | 5 | 152 | 2 | DOID:0050523 (is_implicated_in) | |
| Disease | Jaw Abnormalities | 2.61e-04 | 5 | 152 | 2 | C0022360 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 2.61e-04 | 5 | 152 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | Glioblastoma Multiforme | 2.81e-04 | 111 | 152 | 5 | C1621958 | |
| Disease | retinitis pigmentosa (implicated_via_orthology) | 3.58e-04 | 27 | 152 | 3 | DOID:10584 (implicated_via_orthology) | |
| Disease | Leber congenital amaurosis (is_implicated_in) | 3.90e-04 | 6 | 152 | 2 | DOID:14791 (is_implicated_in) | |
| Disease | non-word reading | 4.03e-04 | 67 | 152 | 4 | EFO_0005299 | |
| Disease | colorectal cancer (implicated_via_orthology) | 4.91e-04 | 30 | 152 | 3 | DOID:9256 (implicated_via_orthology) | |
| Disease | Stage IV Skin Melanoma | 5.44e-04 | 7 | 152 | 2 | C1321872 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 5.44e-04 | 7 | 152 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 5.44e-04 | 7 | 152 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | FEV/FEC ratio | PCSK5 HSPG2 FRAS1 TNIP2 ZFP30 ITGA8 FBLN1 FBN1 SVIL SCUBE3 ADAM33 LTBP2 PLCL1 LNX1 CRB2 AGAP3 | 6.22e-04 | 1228 | 152 | 16 | EFO_0004713 |
| Disease | lateral ventricle volume measurement | 6.53e-04 | 33 | 152 | 3 | EFO_0008487 | |
| Disease | response to tyrosine kinase inhibitor | 7.23e-04 | 8 | 152 | 2 | EFO_0009170 | |
| Disease | microcephaly (is_implicated_in) | 7.23e-04 | 8 | 152 | 2 | DOID:10907 (is_implicated_in) | |
| Disease | body weight | PAPPA2 PCSK5 FAS LRP1B AXIN1 MEX3C CRB1 MOXD1 EYS FBN2 TULP4 SLIT3 LTBP2 PLCL1 LNX1 EPHA4 | 8.24e-04 | 1261 | 152 | 16 | EFO_0004338 |
| Disease | hemangiopericytoma (is_marker_for) | 9.27e-04 | 9 | 152 | 2 | DOID:264 (is_marker_for) | |
| Disease | alopecia areata (is_implicated_in) | 9.27e-04 | 9 | 152 | 2 | DOID:986 (is_implicated_in) | |
| Disease | Adult Hepatocellular Carcinoma | 9.27e-04 | 9 | 152 | 2 | C0279607 | |
| Disease | brain ischemia (is_implicated_in) | 1.15e-03 | 10 | 152 | 2 | DOID:2316 (is_implicated_in) | |
| Disease | Autoimmune Diseases | 1.33e-03 | 42 | 152 | 3 | C0004364 | |
| Disease | Marfan Syndrome | 1.41e-03 | 11 | 152 | 2 | C0024796 | |
| Disease | cortical surface area measurement | RIN3 MCPH1 SEMA5A LAMC3 CPED1 PGF PLEKHM1 AXIN1 FBN1 FBN2 JAG1 PLCL1 LNX1 FBN3 EPHA4 AGAP3 | 1.61e-03 | 1345 | 152 | 16 | EFO_0010736 |
| Disease | serum IgG glycosylation measurement | 1.62e-03 | 523 | 152 | 9 | EFO_0005193 | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 1.62e-03 | 45 | 152 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 1.68e-03 | 12 | 152 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | asthma | ZNF311 RIN3 ERMP1 LRP1B CRB1 TMEM132D SCUBE3 CDK5RAP2 PLCL1 LNX1 NOTCH4 | 1.83e-03 | 751 | 152 | 11 | MONDO_0004979 |
| Disease | cortical thickness | HSPG2 RIN3 MCPH1 LAMC3 CPED1 PLEKHM1 FBN1 FBN2 JAG1 CDK5RAP2 LNX1 CRB2 EPHA4 AGAP3 | 1.90e-03 | 1113 | 152 | 14 | EFO_0004840 |
| Disease | vascular brain injury measurement, vascular brain injury | 1.98e-03 | 13 | 152 | 2 | EFO_0006791, EFO_0006800 | |
| Disease | gallbladder cancer (is_implicated_in) | 1.98e-03 | 13 | 152 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | Alzheimer disease, age at onset | 2.07e-03 | 343 | 152 | 7 | EFO_0004847, MONDO_0004975 | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 2.20e-03 | 50 | 152 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | trimethylamine-N-oxide measurement | 2.30e-03 | 14 | 152 | 2 | EFO_0010541 | |
| Disease | asthma, response to diisocyanate | 2.39e-03 | 261 | 152 | 6 | EFO_0006995, MONDO_0004979 | |
| Disease | lower face morphology measurement | 2.48e-03 | 109 | 152 | 4 | EFO_0010948 | |
| Disease | RS-10-hydroxywarfarin to RS-warfarin ratio measurement | 2.56e-03 | 110 | 152 | 4 | EFO_0803335 | |
| Disease | acute graft vs. host disease, donor genotype effect measurement | 2.65e-03 | 15 | 152 | 2 | EFO_0004599, EFO_0007892 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 2.65e-03 | 15 | 152 | 2 | EFO_0008208 | |
| Disease | Proteinuria | 2.65e-03 | 15 | 152 | 2 | HP_0000093 | |
| Disease | Autosomal recessive primary microcephaly | 2.65e-03 | 15 | 152 | 2 | cv:C3711387 | |
| Disease | facial morphology measurement | 2.96e-03 | 466 | 152 | 8 | EFO_0007841 | |
| Disease | temporal arteritis (is_implicated_in) | 3.02e-03 | 16 | 152 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 3.02e-03 | 16 | 152 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | birth weight, parental genotype effect measurement | 3.24e-03 | 192 | 152 | 5 | EFO_0004344, EFO_0005939 | |
| Disease | obsolete aging | 3.32e-03 | 279 | 152 | 6 | GO_0007568 | |
| Disease | Eye Abnormalities | 3.41e-03 | 17 | 152 | 2 | C0015393 | |
| Disease | Moyamoya Disease | 3.41e-03 | 17 | 152 | 2 | C0026654 | |
| Disease | acute kidney failure (is_marker_for) | 3.41e-03 | 17 | 152 | 2 | DOID:3021 (is_marker_for) | |
| Disease | Malignant neoplasm of skin | 3.53e-03 | 59 | 152 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 3.53e-03 | 59 | 152 | 3 | C0037286 | |
| Disease | Hallux valgus | 3.70e-03 | 60 | 152 | 3 | HP_0001822 | |
| Disease | lymphocyte count | FRAS1 MARCHF8 HKDC1 PTPN22 PRKAG3 MST1R FBN1 ARSA EGF ZNRF3 SUPV3L1 JAG1 NLRC5 LTBP2 RNF39 MEX3B | 3.72e-03 | 1464 | 152 | 16 | EFO_0004587 |
| Disease | age at menarche | 3.77e-03 | 594 | 152 | 9 | EFO_0004703 | |
| Disease | late-onset myasthenia gravis | 3.82e-03 | 18 | 152 | 2 | EFO_1001490 | |
| Disease | behavior or behavioral disorder measurement, personality trait | 3.82e-03 | 18 | 152 | 2 | EFO_0004365, EFO_0004782 | |
| Disease | Squamous cell carcinoma | 3.94e-03 | 124 | 152 | 4 | C0007137 | |
| Disease | puberty onset measurement | 4.05e-03 | 125 | 152 | 4 | EFO_0005677 | |
| Disease | age at diagnosis, type 1 diabetes mellitus | 4.06e-03 | 62 | 152 | 3 | EFO_0004918, MONDO_0005147 | |
| Disease | bone density | 4.09e-03 | 388 | 152 | 7 | EFO_0003923 | |
| Disease | emphysema pattern measurement | 4.26e-03 | 19 | 152 | 2 | EFO_0005850 | |
| Disease | Deaf Mutism | 4.71e-03 | 20 | 152 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 4.71e-03 | 20 | 152 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.71e-03 | 20 | 152 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.71e-03 | 20 | 152 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.71e-03 | 20 | 152 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 4.71e-03 | 20 | 152 | 2 | C0011052 | |
| Disease | intraocular pressure measurement | 5.01e-03 | 509 | 152 | 8 | EFO_0004695 | |
| Disease | Calcium channel blocker use measurement | 5.02e-03 | 213 | 152 | 5 | EFO_0009930 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SQECADILIQHGCPG | 831 | Q96P47 | |
| LCIDSITPCADGIHL | 731 | Q9NR09 | |
| CPLDVSHAICSIGDS | 511 | Q13939 | |
| CGFVQDCGLLIHPEE | 681 | A4D0V7 | |
| DCGLLIHPEETCGLQ | 686 | A4D0V7 | |
| LCLEGVLSCQPHESL | 426 | Q9UGI9 | |
| EDHVIISDSHCCPLG | 246 | Q96Q42 | |
| CEEGQAPVACEETLH | 651 | Q9H2U9 | |
| CPAQRCVALEASGEH | 126 | Q9HCU0 | |
| SPDNGGCEHECVEEV | 236 | Q9HCU0 | |
| DPHRCVDTDECQIAG | 306 | Q9HCU0 | |
| HNVPLCVLENCEFVG | 236 | Q9UK96 | |
| SSDTLETIAPGHDCC | 51 | Q12802 | |
| CPHNDEVIASGSEDC | 91 | Q9BR76 | |
| DCAGQHCSRLLPDLD | 81 | A6QL63 | |
| LGLSHDPDGCCVEAA | 351 | Q9BZ11 | |
| DTCDGCEPGQVRAHL | 521 | Q8N302 | |
| ESCGDIHCAGAVPLL | 186 | Q96C12 | |
| GCVDHPIVLTEAVCN | 126 | Q9H9F9 | |
| NEHTEEGESLLCLAC | 261 | O75179 | |
| HTGACQDVDECQAVP | 241 | Q75N90 | |
| GINCVDTDECSVGHP | 2121 | Q75N90 | |
| ECHDIRQGPCFAEVL | 2291 | Q75N90 | |
| VLSEDLQLHDGPCCS | 1191 | A7MBM2 | |
| ETEIHVGRCLNSQPC | 41 | Q8NET1 | |
| DSIRAHCEENAPLCG | 731 | Q7Z2K6 | |
| ISDCDGAHAPGCLEE | 756 | Q96SN8 | |
| VDKHEIPQESLDGCC | 351 | Q96M43 | |
| ISCQICEHILADPVE | 291 | P15918 | |
| HICNLPEGSCTENDV | 521 | Q5T481 | |
| KGDLCEHEENPCQLR | 4136 | P98160 | |
| ELCQPDHIHICDGSE | 36 | P35558 | |
| QEDDSVPICIHCSAG | 216 | Q9Y2R2 | |
| LLIDEVCCQNDGPHS | 976 | Q8TB72 | |
| DPECCSILHGLVAAV | 116 | Q9NVM9 | |
| GILCIDNVHCGETSD | 146 | Q6NSI4 | |
| CPAHGCDILVDDNTV | 231 | Q9Y4X5 | |
| SDIDECSGNPCLHGA | 4126 | Q14517 | |
| EAVSGDCPLQGLLHC | 261 | A5PL33 | |
| QDVDECSLGANPCEH | 411 | P46531 | |
| DVNECDSQPCLHGGT | 1021 | P46531 | |
| SEEIDECLSHPCQNG | 1181 | P46531 | |
| DCGPSHVLLDGQCLS | 731 | Q86XX4 | |
| HVLLDGQCLSQCPDG | 736 | Q86XX4 | |
| SEDYELLVLQHGCCP | 1216 | Q9HBG6 | |
| CERCGIVHTAQIPDT | 826 | Q9Y561 | |
| VHLSQLCNGVLDCPD | 91 | Q9NZR2 | |
| GILPCHLECSEAATE | 2331 | P78559 | |
| GEAQSEHEPCFIVDC | 576 | Q8NEM0 | |
| EPCLHDGVCIDGINH | 1011 | Q5T1H1 | |
| PDSVEIGLQTCCHIF | 511 | Q9UBB6 | |
| PCHNGGLCEEISQEV | 31 | Q08431 | |
| EVDECASAPCLHGGS | 146 | Q5IJ48 | |
| EREVLECASAPCEHN | 221 | Q5IJ48 | |
| EHEFVELACQCPAVV | 831 | O43861 | |
| APTANICEDIICHAL | 906 | Q9Y3R5 | |
| HENGVCCSDPLSLLE | 796 | Q4FZB7 | |
| VPLVNLCDGHLHCED | 656 | P98073 | |
| PIGNCLCNAGHEERS | 256 | P54764 | |
| PGHDECSSCQEGLQL | 1141 | Q92824 | |
| QCECPRGLVLSEDNH | 246 | Q8WWZ8 | |
| FCDVHPVLELACADT | 176 | Q8NH49 | |
| DGQSICGELSIQEHC | 81 | Q9H792 | |
| CGELSIQEHCENKPV | 86 | Q9H792 | |
| LDDACVSNPCHEDAI | 351 | Q9UM47 | |
| DVDECSIGANPCEHL | 391 | Q9UM47 | |
| VCPEGRTGSHCEQEV | 1071 | Q9UM47 | |
| RTGSHCEQEVDPCLA | 1076 | Q9UM47 | |
| EPLCAVCGQAHSLEE | 11 | Q8TBB1 | |
| SCCTEPEDTGAEIIH | 276 | Q5T0T0 | |
| CEEGFELHGSTQLEC | 461 | P16581 | |
| LHQTGLACECDPQGS | 766 | P07942 | |
| GHADDCDPVTGECLN | 871 | P07942 | |
| REIPLCAGCDQHILD | 26 | Q9UBR4 | |
| NLHTVCEEARCPNIG | 101 | O43766 | |
| CHDDVFIPELITNCG | 606 | A8MYU2 | |
| VNCHLSPIDCEVLAG | 731 | Q96MN2 | |
| HSDEFQCQEDGICIP | 1231 | P98164 | |
| QVARGEDPALQICCH | 476 | P15289 | |
| AQVFHICGPEDVCEA | 211 | Q9ULW8 | |
| HILVDCGEDNLCVPD | 636 | P53708 | |
| CHCVDETQEPELASL | 616 | Q86WI3 | |
| GPILSCVAVCEVIDH | 206 | Q8N5Y8 | |
| KDIDECESGIHNCLP | 261 | P23142 | |
| DIDECALPTGGHICS | 481 | P23142 | |
| LVHCIQSCEPFQADG | 1726 | Q9BXP8 | |
| VLLQAEGEAVPAHCC | 36 | B2RXH4 | |
| QPGEICNEADLCDPH | 81 | O95389 | |
| SHLGNELEGTEELCC | 296 | O14523 | |
| SECSHDCVLTSEGPL | 406 | P01133 | |
| VSPAGILCVADQCHG | 211 | Q9UKT7 | |
| VDENECLSAHICGGA | 2606 | P35555 | |
| CAGLRDAHEENPESI | 456 | O15169 | |
| GEPCDQLHVCDASQG | 61 | O76076 | |
| LSDCEGSVHCEVPSE | 1976 | Q9NSI6 | |
| NECDDLNGPAVLCVH | 1776 | Q14767 | |
| NRDISILQCHGDCDP | 161 | O75608 | |
| CPHECFEAILSLDTG | 51 | Q6UWN5 | |
| ILSHCCVGLEPGEDA | 86 | Q15051 | |
| PRCGGTNHDQCLLDE | 121 | A6NGE4 | |
| VDRNECLEIPNVCSH | 1891 | P35556 | |
| GDHCELNTDECASQP | 256 | P82279 | |
| GIHCEEDVNECSSNP | 391 | P82279 | |
| NHPELILLCDSCDSG | 901 | Q96T23 | |
| CSGVLEEPVQAPHCE | 21 | Q9H4P4 | |
| REDNAGCVHDCVNIP | 76 | Q8IX30 | |
| HQGAVCEFCQPRESE | 1021 | P28340 | |
| LCKEGEDEHPQCLNS | 156 | Q8N6C8 | |
| HISCETPAVLELACA | 176 | Q8NH74 | |
| QLADVCLDTPLCNGH | 916 | O15294 | |
| RPTAHDANCACEIEL | 211 | Q8TB24 | |
| GDHCERDIDECASNP | 481 | P78504 | |
| LDDQCFVHPCTGVGE | 921 | P78504 | |
| CERGCDVNLPDAHSD | 551 | Q96AX9 | |
| IDCHQGQCVLETSGP | 1101 | Q9H195 | |
| CFESEVIAALVPCGH | 521 | Q6ZN04 | |
| SPLDAAVECHRGECQ | 141 | P02790 | |
| CDICHQDDASVIPAR | 856 | Q9Y4G2 | |
| SLLVCHCAAPFEEQG | 3166 | Q5T011 | |
| VCPNCGSDHVVLLAV | 706 | Q8N1F8 | |
| RLPHCVSEESLACDN | 861 | Q9BYH1 | |
| PVEGNLLEVACHCSS | 1891 | O95425 | |
| VCQDLDPGDCKELHN | 1076 | Q14C87 | |
| CNGELSHDCDGPITD | 111 | Q96LT4 | |
| LEPSEADCIAVQHVC | 361 | Q2TB90 | |
| LCKEGEDEHPQCLNS | 156 | O75019 | |
| LCKEGEDEHPQCLNS | 156 | Q8NHL6 | |
| VDKHEIPQESLDGCC | 351 | Q5VWK0 | |
| CNAGPEDIQSRIGHC | 446 | Q9UL63 | |
| SCGEDGHIRVQCINP | 416 | Q9UL41 | |
| CFENEVIAALVPCGH | 611 | Q5U5Q3 | |
| NEDGLTALHQCCIDD | 101 | Q96I34 | |
| HILECCDGLAQDVIG | 281 | Q92529 | |
| GLCAEEVHLCGEPAA | 311 | Q8IYB8 | |
| LICCPGSDEKVFEVH | 16 | P13598 | |
| NCDHSEDAGLVCTGP | 286 | A1L4H1 | |
| CSEDVDECETQGPPH | 311 | Q99466 | |
| DVDECLDQPCHPTGT | 1006 | Q99466 | |
| LGLHTEEALCNTQPC | 881 | Q13591 | |
| PVCGNHLLEVGEDCD | 421 | O15204 | |
| SDGSHCPIILCGDLN | 421 | Q9UNK9 | |
| CGVVCEHSPFDGIVL | 436 | P28329 | |
| VVLCEALSHPDCALQ | 931 | Q7RTR0 | |
| CDEVIDHCVPELNLC | 1031 | O75094 | |
| PHCLQCFSDEQGEEL | 406 | Q8NFZ5 | |
| EQSICIDCHAPIGGI | 4521 | Q63HN8 | |
| CLGEPDHNEALSVDA | 166 | O95985 | |
| EHGPVLCSDSNILCL | 6 | Q9NRJ4 | |
| CIEIHGIPADCSEQR | 751 | Q15111 | |
| SCGLEEQESPHEVCF | 111 | Q9Y2G7 | |
| VCTHLGCVPIANAGD | 216 | P47985 | |
| LTCVDLDECAIPGAH | 61 | P07911 | |
| DALVCADPCQAHRTL | 166 | P07911 | |
| NEECPGECLVTGQSH | 381 | P04275 | |
| PEFQSEGHCTLECLE | 356 | Q6UVY6 | |
| LLDNEKCDHEGPCSV | 1206 | Q13129 | |
| LCDEGHGLEVEINCT | 106 | P25445 | |
| CCGDENLHCVPVETA | 86 | P49763 | |
| VHCEGGEPRLAACQS | 256 | Q8WTU2 | |
| VCHQELEDPGEARAC | 291 | Q969T3 | |
| QACLGACAPHLEEKL | 231 | O75191 | |
| EICGCALQLDLHDDP | 356 | Q8IZM8 | |
| VIESVVECPRNCHGN | 511 | Q9P273 | |
| NSLQKEPHGEDLLCC | 126 | O75678 | |
| GLHTEEALCATQACP | 951 | Q9P283 | |
| ECLIPVHVDGDGHCL | 206 | Q96JH7 | |
| IEHCQIHTGEKPFEC | 321 | O75290 | |
| ECIDCLPGTFLNHTE | 516 | Q8TE23 | |
| IAEAGPHEDCPCQQI | 81 | Q9UIE0 | |
| VDCDLGLPSDCQGTH | 836 | Q9ULT6 | |
| PAVSVGLEECNHECK | 201 | Q658N2 | |
| FNEDILCPHGELCIS | 646 | Q86UV5 | |
| VLEDHTAIGQEQCCP | 621 | O43164 | |
| QDGAPLQVCVDGECH | 926 | Q04912 | |
| ACHILECPEGLAQDV | 286 | P29353 | |
| CGGSFEDPVLLACEH | 91 | Q9H2S5 | |
| EQIHSGEKPHVCNEC | 266 | Q5JNZ3 | |
| HASECGPDVAGQLAC | 276 | Q9Y6N6 |